CYCN
Cyclerion Therapeutics Inc
NASDAQ: CYCN · HEALTHCARE · BIOTECHNOLOGY
$3.31
-0.30% today
Updated 2026-04-30
Market cap
$12.73M
P/E ratio
—
P/S ratio
6.14x
EPS (TTM)
$-1.11
Dividend yield
—
52W range
$1 – $8
Volume
5.6M
Cyclerion Therapeutics Inc (CYCN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-170.10%
Operating margin
-81.80%
ROE
-39.30%
ROA
-31.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | $0.00 | $-63.55M | — | — | — |
| 2017 | $0.00 | $-93.92M | — | — | — |
| 2018 | $0.00 | $-115.25M | — | — | — |
| 2019 | $4.51M | $-123.01M | -2,010.94% | -2,774.28% | -2,729.27% |
| 2020 | $2.30M | $-77.80M | -2,357.06% | -3,539.42% | -3,388.59% |
| 2021 | $3.32M | $-51.65M | 100.00% | -1,662.50% | -1,555.63% |
| 2022 | $297000.00 | $-44.08M | -1,778.45% | -6,242.42% | -14,841.08% |
| 2023 | $0.00 | $-5.26M | — | — | — |
| 2024 | $2.00M | $-3.06M | 100.00% | -181.40% | -152.85% |
| 2025 | $2.07M | $-3.53M | 100.00% | -239.78% | -170.11% |